Clinical Trial Update: Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial from UCSF evaluated a conditioning regimen of busulfan, antithymocyte globulin, and fludarabine followed by donor stem cell trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Amegakaryocytic Thrombocytopenia
• Congenital Neutropenia
• Diamond-blackfan Anemia
• Fanconi Anemia
• Leukemia
• Thrombocytopenia

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Congenital Amegakaryocytic Thrombocytopenia, Diamond-blackfan Anemia | Phase 1, Phase 2 | Status: COMPLETED